Search research articles
Contact Us
Filters
Showing results (221-230 of 239) with videos related to
Page
of 24
Sort By:
Radiology
|
October 17, 2019
Diffusion Tensor MRI to Distinguish Progressive Supranuclear Palsy from α-Synucleinopathies
Nicola Spotorno, Sara Hall, David J Irwin, et al.
Brain Communications
|
February 5, 2021
Measuring cerebral perfusion with [<sup>11</sup>C]-PiB R1 in Down syndrome: associations with amyloid burden and longitudinal cognitive decline
Elijah Mak, Monika Grigorova, Jessica Beresford-Webb, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 10, 2018
Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype
Hisham Ziauddeen, Liam J Nestor, Naresh Subramaniam, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 26, 2016
Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype
Hisham Ziauddeen, Liam J Nestor, Naresh Subramaniam, et al.
Addiction Biology
|
September 8, 2016
Acute naltrexone does not remediate fronto-striatal disturbances in alcoholic and alcoholic polysubstance-dependent populations during a monetary incentive delay task
Liam J Nestor, Anna Murphy, John McGonigle, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 3, 2017
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence
Anna Murphy, Liam J Nestor, John McGonigle, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 13, 2017
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence
Anna Murphy, Liam J Nestor, John McGonigle, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 14, 2017
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence
Anna Murphy, Liam J Nestor, John McGonigle, et al.
The European Journal of Neuroscience
|
November 8, 2018
Naltrexone differentially modulates the neural correlates of motor impulse control in abstinent alcohol-dependent and polysubstance-dependent individuals
Liam J Nestor, Louise M Paterson, Anna Murphy, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
January 8, 2020
Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report
Elijah Mak, Anastasia Bickerton, Concepcion Padilla, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 239) with videos related to
Sort By:
Page
of 24
Radiology
|
October 17, 2019
Diffusion Tensor MRI to Distinguish Progressive Supranuclear Palsy from α-Synucleinopathies
Nicola Spotorno, Sara Hall, David J Irwin, et al.
Brain Communications
|
February 5, 2021
Measuring cerebral perfusion with [<sup>11</sup>C]-PiB R1 in Down syndrome: associations with amyloid burden and longitudinal cognitive decline
Elijah Mak, Monika Grigorova, Jessica Beresford-Webb, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 10, 2018
Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype
Hisham Ziauddeen, Liam J Nestor, Naresh Subramaniam, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 26, 2016
Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype
Hisham Ziauddeen, Liam J Nestor, Naresh Subramaniam, et al.
Addiction Biology
|
September 8, 2016
Acute naltrexone does not remediate fronto-striatal disturbances in alcoholic and alcoholic polysubstance-dependent populations during a monetary incentive delay task
Liam J Nestor, Anna Murphy, John McGonigle, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 3, 2017
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence
Anna Murphy, Liam J Nestor, John McGonigle, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 13, 2017
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence
Anna Murphy, Liam J Nestor, John McGonigle, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 14, 2017
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence
Anna Murphy, Liam J Nestor, John McGonigle, et al.
The European Journal of Neuroscience
|
November 8, 2018
Naltrexone differentially modulates the neural correlates of motor impulse control in abstinent alcohol-dependent and polysubstance-dependent individuals
Liam J Nestor, Louise M Paterson, Anna Murphy, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
January 8, 2020
Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report
Elijah Mak, Anastasia Bickerton, Concepcion Padilla, et al.
Page
of 24